Vanguard Global Advisers’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.16M Sell
14,767
-179
-1% -$12.4K ﹤0.01% 1625
2026
Q2
$941K Sell
14,946
-1,481
-9% -$94.6K ﹤0.01% 1783
2026
Q1
$1.15M Buy
+16,427
New +$1.15M ﹤0.01% 1561

Other funds holding TARS

Vanguard Global Advisers's TARS Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Tarsus Pharmaceuticals (TARS) stake by 1.2% in Q3 2026, selling an estimated $12.4K and leaving 14,767 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

Vanguard Global Advisers first reported a position in TARS in Q1 2026 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Vanguard Global Advisers held 14,767 shares of Tarsus Pharmaceuticals worth $1.16M as of Q3 2026.
  • Vanguard Global Advisers sold 179 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $12.4K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1625 holding.
  • Vanguard Global Advisers first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.